Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Biotechnology (2)
Nature Medicine (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (2)
Comments & Opinion (1)

Subject Check one or more subjects to show results from those subjects only.

Biotechnology
Business and industry
Cancer
Diseases
Immunology
Medical research
Microbiology
Systems biology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–3 of 3 results

Advanced filters: Author: Sreyan Chowdhury Clear advanced filters

The emerging landscape of engineered bacteria cancer therapies

Our ability to use engineered bacteria for cancer therapy is rapidly expanding. A survey of preclinical, clinical and commercial efforts provides an overview of the state of the field, revealing trends that could inform future directions.

Edward R. Ballister
Alexander Michels
Tal Danino
Comments & Opinion01 Apr 2025
Nature Biotechnology

Volume: 43, P: 672-676
Programmable bacteria induce durable tumor regression and systemic antitumor immunity

Local release of an anti-CD47 nanobody from an engineered non-pathogenic Escherichia coli strain is safe and enhances activation of tumor-infiltrating T cells, slowing tumor growth in mice.

Sreyan Chowdhury
Samuel Castro
Tal Danino
Research03 Jul 2019
Nature Medicine

Volume: 25, P: 1057-1063
A programmable encapsulation system improves delivery of therapeutic bacteria in mice

Transient capsule induction allows engineered bacteria to evade initial immune surveillance in a colorectal cancer model.

Tetsuhiro Harimoto
Jaeseung Hahn
Tal Danino
ResearchOpen Access17 Mar 2022
Nature Biotechnology

Volume: 40, P: 1259-1269